Why Broadcom Stock Slumped Today

Broadcom shares fell 9.7% after-hours/into the close as fiscal Q3 results were “good but not good enough” versus a year marked by AI-bull expectations. Revenue rose 47% to $13.07B (roughly in line with $13.03B consensus) with adjusted EPS of $1.24 vs $1.22 expected, but guidance for Q4 revenue of ~$14.0B missed the ~$14.13B consensus. Despite steady profitability (adjusted EBITDA $8.22B; 63% margin) and an AI revenue target of $12B for the year supported by accelerator demand, the slightly weaker outlook drove the selloff alongside broader tech pressure from a weak employment report.

Analysis

AVGO is being repriced from a scarce-AI compounder to a mature semi/software platform that still needs to prove it deserves a premium multiple. The market is signaling that “AI exposure” is no longer enough; investors now want clear evidence of acceleration versus just participation. That matters for the whole AI supply chain because it raises the bar for any stock trading on second-derivative capex optimism, especially names where software dilution can mask slower core semiconductor growth.

Near term, the biggest risk is not fundamental deterioration but multiple compression as estimates get incrementally reset over the next 1-2 earnings cycles. If hyperscaler spend remains strong, NVDA is the cleaner way to express that view because the operating leverage is more direct; AVGO’s hybrid profile likely limits upside capture even if AI demand stays healthy. A secondary spillover is to networking and custom silicon peers: the market may start demanding faster backlog conversion and higher forward revisions before paying up again.

Contrarian read: the selloff may be more about positioning than a broken thesis. If management continues to prove integration discipline and AI revenue tracks higher into the next quarter, the current drawdown could reverse quickly. The thesis is falsified if AVGO stabilizes and the next guide/buy-side checks show no slowdown in hyperscaler orders; in that case, this becomes a buying opportunity rather than a de-rating event.

Key Decisions for Investors

• Short AVGO tactically into any relief rally over the next 5-10 trading days; risk/reward favors a 5-8% further de-rating if the market keeps trimming AI multiples, but cover if the stock reclaims the pre-earnings gap on improving semis breadth.
• Pair trade: long NVDA / short AVGO for 4-8 weeks to isolate cleaner AI operating leverage versus a diversified platform with software dilution; thesis breaks if AVGO’s next guidance materially re-accelerates or if NVDA loses relative strength on capex concerns.
• Avoid adding to AVGO until the next hyperscaler capex read-through or analyst revision cycle confirms the demand trajectory; best entry is after post-earnings selling exhausts, not on the first bounce.
• If you need AI beta but want lower event risk, rotate exposure from AVGO into NVDA on weakness; AVGO needs multiple support from execution proof, while NVDA remains the higher-conviction expression of AI spend.
• Watch for a 2-3 week stabilization in AVGO plus upward EPS revisions; that would signal the market has finished repricing and could justify re-entering on the long side.